CROSS CTRY HEALTHCARE INC's ticker is CCRN and the CUSIP is 227483104. A total of 155 filers reported holding CROSS CTRY HEALTHCARE INC in Q2 2021. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $18,376,351 | -30.6% | 1,327,771 | -6.2% | 0.00% | 0.0% |
Q1 2024 | $26,486,591 | -15.7% | 1,414,882 | +1.9% | 0.00% | -50.0% |
Q4 2023 | $31,421,105 | -1.9% | 1,387,858 | +7.5% | 0.00% | 0.0% |
Q3 2023 | $32,017,376 | -11.1% | 1,291,544 | +0.7% | 0.00% | 0.0% |
Q2 2023 | $36,001,593 | +25.3% | 1,282,108 | -0.4% | 0.00% | 0.0% |
Q1 2023 | $28,721,666 | -56.8% | 1,286,813 | -48.6% | 0.00% | 0.0% |
Q4 2022 | $66,548,392 | +87.0% | 2,504,644 | +99.7% | 0.00% | 0.0% |
Q3 2022 | $35,583,000 | +40.3% | 1,254,241 | +3.0% | 0.00% | 0.0% |
Q2 2022 | $25,358,000 | -0.9% | 1,217,372 | +3.1% | 0.00% | +100.0% |
Q1 2022 | $25,596,000 | -16.3% | 1,181,174 | +7.2% | 0.00% | 0.0% |
Q4 2021 | $30,586,000 | +18.7% | 1,101,802 | -9.2% | 0.00% | 0.0% |
Q3 2021 | $25,768,000 | +31.4% | 1,213,189 | +2.1% | 0.00% | 0.0% |
Q2 2021 | $19,613,000 | +44.2% | 1,187,951 | +9.1% | 0.00% | 0.0% |
Q1 2021 | $13,603,000 | +44.3% | 1,089,118 | +2.5% | 0.00% | 0.0% |
Q4 2020 | $9,426,000 | +32.8% | 1,062,709 | -2.8% | 0.00% | – |
Q3 2020 | $7,099,000 | +0.3% | 1,093,794 | -4.8% | 0.00% | -100.0% |
Q2 2020 | $7,080,000 | -11.4% | 1,149,392 | -3.0% | 0.00% | 0.0% |
Q1 2020 | $7,988,000 | -49.7% | 1,185,092 | -13.4% | 0.00% | 0.0% |
Q4 2019 | $15,895,000 | +16.4% | 1,367,881 | +3.2% | 0.00% | 0.0% |
Q3 2019 | $13,654,000 | +13.5% | 1,325,602 | +3.3% | 0.00% | 0.0% |
Q2 2019 | $12,035,000 | +30.8% | 1,283,002 | -2.0% | 0.00% | 0.0% |
Q1 2019 | $9,199,000 | +3.1% | 1,308,578 | +7.5% | 0.00% | 0.0% |
Q4 2018 | $8,919,000 | -13.7% | 1,216,799 | +2.8% | 0.00% | 0.0% |
Q3 2018 | $10,336,000 | -15.1% | 1,184,053 | +9.5% | 0.00% | 0.0% |
Q2 2018 | $12,171,000 | +2.0% | 1,081,636 | +0.7% | 0.00% | 0.0% |
Q1 2018 | $11,931,000 | +3.1% | 1,073,856 | +18.4% | 0.00% | 0.0% |
Q4 2017 | $11,568,000 | -7.3% | 906,789 | +3.4% | 0.00% | 0.0% |
Q3 2017 | $12,484,000 | +10.3% | 877,271 | +0.0% | 0.00% | 0.0% |
Q2 2017 | $11,323,000 | -1.3% | 876,998 | +9.8% | 0.00% | 0.0% |
Q1 2017 | $11,470,000 | +1.3% | 798,547 | +10.0% | 0.00% | 0.0% |
Q4 2016 | $11,328,000 | +38.4% | 725,878 | +4.5% | 0.00% | 0.0% |
Q3 2016 | $8,187,000 | -22.9% | 694,890 | -8.9% | 0.00% | 0.0% |
Q2 2016 | $10,619,000 | +4.7% | 762,640 | -12.5% | 0.00% | 0.0% |
Q1 2016 | $10,139,000 | -17.3% | 871,678 | +16.6% | 0.00% | 0.0% |
Q4 2015 | $12,256,000 | +52.8% | 747,731 | +26.8% | 0.00% | 0.0% |
Q3 2015 | $8,023,000 | +13.4% | 589,672 | +5.7% | 0.00% | 0.0% |
Q2 2015 | $7,074,000 | +8.6% | 558,020 | +1.6% | 0.00% | 0.0% |
Q1 2015 | $6,515,000 | +3.1% | 549,274 | +8.4% | 0.00% | 0.0% |
Q4 2014 | $6,317,000 | +37.1% | 506,627 | +2.1% | 0.00% | – |
Q3 2014 | $4,609,000 | +37.7% | 496,440 | -3.3% | 0.00% | – |
Q2 2014 | $3,347,000 | -25.1% | 513,229 | -7.4% | 0.00% | -100.0% |
Q1 2014 | $4,471,000 | -42.8% | 554,150 | -48.0% | 0.00% | – |
Q4 2013 | $7,816,000 | +145.3% | 1,064,687 | +102.3% | 0.00% | – |
Q3 2013 | $3,186,000 | +15.1% | 526,175 | -2.0% | 0.00% | – |
Q2 2013 | $2,768,000 | – | 536,641 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Simcoe Capital Management, LLC | 1,143,625 | $23,822,000 | 3.28% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 2,194,340 | $45,708,000 | 1.59% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 704,526 | $14,676,000 | 1.51% |
Mesirow Financial Investment Management, Inc. | 12,643 | $263,000 | 1.27% |
Aristotle Capital Boston, LLC | 1,638,612 | $34,132,000 | 1.02% |
Zebra Capital Management LLC | 14,351 | $299,000 | 0.88% |
Alpha DNA Investment Management LLC | 49,398 | $1,028,000 | 0.88% |
SummerHaven Investment Management, LLC | 55,577 | $1,158,000 | 0.78% |
GLOBEFLEX CAPITAL L P | 145,700 | $3,035,000 | 0.74% |
OBERWEIS ASSET MANAGEMENT INC/ | 96,900 | $2,018,000 | 0.51% |